DWA
RCEL icon

Dorsey Wright & Associates’s Avita Medical RCEL Stock Holding History

Dorsey Wright & Associates’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,418
Closed -$20.7K – 255
2023
Q3 		$20.7K Sell
1,418
-49
-3% -$829 0.01% 246
2023
Q2 		$25K Buy
+1,467
New +$21.5K 0.01% 212

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dorsey Wright & Associates's RCEL Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 1,418 shares — an estimated $20.7K sold.

Dorsey Wright & Associates first reported a position in RCEL in Q2 2023 and held it in 2 quarters. The position peaked at $25K in Q2 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,418 Avita Medical shares in Q4 2023, an estimated $20.7K.
  • Dorsey Wright & Associates first reported a position in Avita Medical in Q2 2023 and held it in 2 quarters.
  • Dorsey Wright & Associates's Avita Medical position peaked at $25K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.